Compile Data Set for Download or QSAR
maximum 50k data
Found 99 for UniProtKB: Q14957
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557699(US11358971, Compound 1h | US11466027, Compound 1l)
Affinity DataKi:  63nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557694(US11358971, Compound 1c | US11466027, Compound 1e)
Affinity DataKi:  96nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557693(US11358971, Compound 1b | US11466027, Compound 1d)
Affinity DataKi:  140nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557667(US11358971, Compound 1a | US11466027, Compound 1c)
Affinity DataKi:  170nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557701(US11358971, Compound 1j | US11466027, Compound 1n)
Affinity DataKi:  180nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM576021((R)-2-amino-3-[(7- isopropylthieno[3,2- b]pyridine...)
Affinity DataKi:  220nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557698(US11358971, Compound 1g | US11466027, Compound 1k)
Affinity DataKi:  220nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557702(US11358971, Compound 1k | US11466027, Compound 1o)
Affinity DataKi:  260nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM576017((R)-2-amino-3-[(7- ethylthieno[3,2-b]pyridine- 2- ...)
Affinity DataKi:  270nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557697(US11358971, Compound 1f | US11466027, Compound 1i)
Affinity DataKi:  360nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557703(US11358971, Compound 1l | US11466027, Compound 1p)
Affinity DataKi:  490nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557696(US11358971, Compound 1e | US11466027, Compound 1h)
Affinity DataKi:  690nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557695(US11358971, Compound 1d | US11466027, Compound 1g)
Affinity DataKi:  860nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM576026((R)-2-amino-3-[(7- ethoxythieno[3,2- b]pyridine-2-...)
Affinity DataKi:  870nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM557700(US11358971, Compound 1i | US11466027, Compound 1m)
Affinity DataKi:  3.90E+3nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM575980((R)-2-amino-3-[[7- thieno[3,2-b]pyridine-2- carbon...)
Affinity DataKi:  7.40E+3nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C(Homo sapiens (Human))
Academy Of Sciences Of The Czech Republic V.V.I.

Curated by ChEMBL
LigandPNGBDBM50498430(CHEMBL3594112)
Affinity DataIC50:  400nMAssay Description:Inhibition of recombinant GluN1/GluN2C receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of glutamate-evoked current by whol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436102(CHEMBL2397256 | US10273214, Example 1180-26)
Affinity DataIC50:  800nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436101(CHEMBL2397257 | US10273214, Example 1180-27)
Affinity DataIC50:  1.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436082(CHEMBL2397103 | US10273214, Example 1391)
Affinity DataIC50:  1.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436090(CHEMBL2397119 | US10273214, Example 1180-31)
Affinity DataIC50:  1.20E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50503149(CHEMBL4464605)
Affinity DataIC50:  2.00E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436072(CHEMBL2397211 | US10273214, Example 1426)
Affinity DataIC50:  2.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436078(CHEMBL2397109 | US10273214, Example 1180-12)
Affinity DataIC50:  2.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436085(CHEMBL2397093 | US10273214, Example 1180-15)
Affinity DataIC50:  2.40E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50503153(CHEMBL4544421)
Affinity DataIC50:  2.60E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436067(CHEMBL2397233 | US10273214, Example 1366)
Affinity DataIC50:  3.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436079(CHEMBL2397108 | US10273214, Example 1180-10)
Affinity DataIC50:  3.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436060(CHEMBL2397100 | US10273214, Example 1390)
Affinity DataIC50:  3.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436061(CHEMBL2397099 | US10273214, Example 1368)
Affinity DataIC50:  4.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436083(CHEMBL2397097 | US10273214, Example 1425)
Affinity DataIC50:  5.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50503146(CHEMBL4447266)
Affinity DataIC50:  5.40E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436076(CHEMBL2397124 | US10273214, Example 1180-18)
Affinity DataIC50:  6.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436081(CHEMBL2397105 | US10273214, Example 1392)
Affinity DataIC50:  6.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436104(CHEMBL2397254 | US10273214, Example 1180-21)
Affinity DataIC50:  7.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436075(CHEMBL2397208 | US10273214, Example 1369)
Affinity DataIC50:  7.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50440056(CHEMBL2333944)
Affinity DataIC50:  7.00E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50324401((E)-4-(6-Methoxy-2-(3-nitrostyryl)-4-oxoquinazolin...)
Affinity DataIC50:  7.10E+3nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436069(CHEMBL2397221 | US10273214, Example 1486)
Affinity DataIC50:  9.00E+3nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436062(CHEMBL2397252 | US10273214, Example 1180-19)
Affinity DataIC50:  1.00E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 1/2C(Homo sapiens (Human))
Academy Of Sciences Of The Czech Republic V.V.I.

Curated by ChEMBL
LigandPNGBDBM436689(N-Cyclopropyl-2-[2-oxo-6-[3-(trifluoromethyl)pheny...)
Affinity DataIC50: >1.00E+4nMAssay Description:Negative allosteric modulation of recombinant human GluN1a/GluN2C expressed in CHO-T-REx cells assessed as inhibition of glutamate/glycine-induced re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50236939(CHEMBL2333945)
Affinity DataIC50: >1.00E+4nMAssay Description:Negative allosteric modulation of human GluN2C receptor expressed in xenopus laevis oocytes assessed as reduction in 3 uM glycine-induced channel cur...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Homo sapiens (Human))
Academy Of Sciences Of The Czech Republic V.V.I.

Curated by ChEMBL
LigandPNGBDBM409486(N-Cyclopropyl-2-[6-[3-(trifluoromethyl)phenyl]pyrr...)
Affinity DataIC50: >1.00E+4nMAssay Description:Negative allosteric modulation of recombinant human GluN1a/GluN2C expressed in CHO-T-REx cells assessed as inhibition of glutamate/glycine-induced re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436105(CHEMBL2397253 | US10273214, Example 1180-20)
Affinity DataIC50:  1.10E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436064(CHEMBL2397250 | US10273214, Example 1180-25)
Affinity DataIC50:  1.20E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436084(CHEMBL2397095 | US10273214, Example 1180)
Affinity DataIC50:  1.20E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50498439(CHEMBL1179566)
Affinity DataIC50:  1.20E+4nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50436080(CHEMBL2397107 | US10273214, Example 1180-16)
Affinity DataIC50:  1.30E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM50379184(CHEMBL2010868)
Affinity DataIC50:  1.50E+4nMAssay Description:Negative allosteric modulation of GluN2C receptor (unknown origin) expressed in xenopus laevis oocytes assessed as reduction in glycine-induced chann...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Homo sapiens (Human))
Emory University

US Patent
LigandPNGBDBM381963(US10273214, Example 1434)
Affinity DataIC50:  1.60E+4nMAssay Description:The assay involves using a cell line that expresses the NR1 subunit together with either NR2C or NR2D. These cell lines can be prepared by transfecti...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 99 total ) | Next | Last >>
Jump to: